News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 244108

Saturday, 12/12/2015 7:42:45 PM

Saturday, December 12, 2015 7:42:45 PM

Post# of 347009
Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL :


---------------------

Frontiers in Medical Sciences Lecture Series 240-
Myeloid-derived suppressor cells are coming to age

Last updated :2015-12-07

Topic: Myeloid-derived suppressor cells are coming to age
Speaker: Prof. Dmitry I. Gabrilovich (The Wistar Institute, University of Pennsylvania)
Chair: Professor Jie Zhou (Zhongshan School of Medicine, SYSU)
Time: 15:00, Thursday, December 10, 2015
Venue: Lecture Room, 4th Floor, Yongsheng Building, North Campus, SYSU
Organizer: Zhongshan School of Medicine, SYSU

Brief introduction:
Prof. Dmitry I. Gabrilovich, Professor in tumor immunology from the Wistar Institute, Perelman School of Medicine, University of Pennsylvania.He was recruited into the “Foreign Experts of The Thousand Talents Plan”of China in 2015.Prof. Gabrilovich obtained his Ph.D. in Central Institute for Epidemiology of Russia in 1989. After that, he was faculty in University of South Florida, the Wistar Institute and University of Pennsylvania from assistant to full professor.Prof. Gabrilovich is the world-leading scientist in the field of Myeloid-derived suppressor cells (MDSC), who discovered and defined MDSCs. He has done many highly original research in the field of MDSC and tumor, from basic, translational study to clinical immunotherapy.He published 228 SCI papers in journals such as Nature Medicine, Nature Immunology and Immunity. He is one of the most cited scientists in the world for many years with h-index as high as 68(date to January 2015).

http://www.sysu.edu.cn/2012/en/announcements/24519.htm

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y